Anthropic's IPO filing tempers its claims that Claude will transform biology
AIAnthropic's IPO filing acknowledges the company lacks experience in physical experimentation and drug development, after CEO Dario Amodei repeatedly predicted AI would revolutionize biology. The filing says its life sciences work will require handling hazardous materials, lab equipment and regulations outside its software history.
Source details
Wired · AI · Emily Mullin · wired.comPublished · added here
Original title: Anthropic Says It Will Revolutionize Biology—Some Day